Puma Biotechnology Inc (PBYI)
2.985
+0.01
(+0.34%)
USD |
NASDAQ |
Nov 14, 16:00
2.985
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Price to Book Value: 3.018 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 3.008 |
| November 12, 2024 | 3.246 |
| November 11, 2024 | 3.337 |
| November 08, 2024 | 2.912 |
| November 07, 2024 | 3.064 |
| November 06, 2024 | 3.094 |
| November 05, 2024 | 2.993 |
| November 04, 2024 | 2.983 |
| November 01, 2024 | 2.983 |
| October 31, 2024 | 2.882 |
| October 30, 2024 | 2.872 |
| October 29, 2024 | 2.821 |
| October 28, 2024 | 2.861 |
| October 25, 2024 | 2.983 |
| October 24, 2024 | 2.831 |
| October 23, 2024 | 2.841 |
| October 22, 2024 | 2.872 |
| October 21, 2024 | 2.841 |
| October 18, 2024 | 2.912 |
| October 17, 2024 | 2.861 |
| October 16, 2024 | 2.912 |
| October 15, 2024 | 2.882 |
| October 14, 2024 | 2.882 |
| October 11, 2024 | 2.882 |
| October 10, 2024 | 2.74 |
| Date | Value |
|---|---|
| October 09, 2024 | 2.679 |
| October 08, 2024 | 2.649 |
| October 07, 2024 | 2.690 |
| October 04, 2024 | 2.679 |
| October 03, 2024 | 2.548 |
| October 02, 2024 | 2.487 |
| October 01, 2024 | 2.629 |
| September 30, 2024 | 2.578 |
| September 27, 2024 | 2.609 |
| September 26, 2024 | 2.588 |
| September 25, 2024 | 2.578 |
| September 24, 2024 | 2.578 |
| September 23, 2024 | 2.578 |
| September 20, 2024 | 2.629 |
| September 19, 2024 | 2.588 |
| September 18, 2024 | 2.528 |
| September 17, 2024 | 2.629 |
| September 16, 2024 | 2.548 |
| September 13, 2024 | 2.558 |
| September 12, 2024 | 2.538 |
| September 11, 2024 | 2.528 |
| September 10, 2024 | 2.416 |
| September 09, 2024 | 2.346 |
| September 06, 2024 | 2.275 |
| September 05, 2024 | 2.326 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.275
Minimum
Sep 06 2024
55.58
Maximum
May 13 2020
12.08
Average
7.178
Median
Aug 03 2022
Price to Book Value Benchmarks
| Pfizer Inc | 1.598 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.8831 |
| Theriva Biologics Inc | 0.0530 |
Price to Book Value Related Metrics
| PE Ratio | 16.58 |
| PS Ratio | 0.6549 |
| Price to Free Cash Flow | 4.316 |
| Price | 2.985 |
| Earnings Yield | 6.03% |
| Market Cap | 146.40M |
| Operating PE Ratio | 7.348 |
| Normalized PE Ratio | 15.50 |